Abstract:Objective The study assessed the clinical characteristics and response to acute intravenous antiarrhythmic drug therapy of supraventricular tachycardia (SVT) in children.Methods This was a multicenter prospective descriptive study including 257 children from First Hospital of Tsinghua University,Peking University First Hospital,Children's Hospital Affiliated to Capital Institute of Pediatrics and Beijing Anzhen Hospital who received intravenous antiarrhythmic drug therapy for SVT from July 2014 to February 2017.The clinical and tachycardia features,response to intravenous antiarrhythmic drug therapy of these children were characterized.Statistical analyses were performed using t test,Mann-Whitney U test,x2 test and H test.Results The onset of SVT occurred at any age with a distribution with positive skewness,57.6％ (n=148) children＜l year,17.5％ (n=45) childrenl ～＜3 years,10.5％ (n=27)children 3 ～＜6 years and 14.4％ (n=37) children ≥ 6 years of age.The percentages of SVT types were 49.4％ (n=127) for atrioventricular reentry tachycardia (AVRT),4.3％ (n=11) for atrioventricular nodal reentry tachycardia (AVNRT),26.8％ (n=69) for unclassified paroxysmal SVT and 19.5％ (n=50) for atrial tachycardia (AT),respectively.Tachycardia-induced cardionyopathy (TIC)secondary to SVT developed in 30 of 225 (13.3％).Left ventricular ejection fraction (LVEF) of the 27 children attacked by TIC returned to normal after successful control of SVT (41.1％-±6.3％ vs.60.3％±9.2％,t=-10.397,P=0.000).Complete termination of SVT by antiarrhythmic drugs was achieved in 164 of 257 (63.8％),partial termination rate was 18.7％ (48 of 257) and failure to terminate rate was 17.5％ (45 of 257).Propafenone (complete cardioversion in 98 (73.1％) of 134) and amiodarone (complete cardioversion in 23 (76.7％) of 30) showed better efficacy for SVT termination than adenosine (complete cardioversion in 26 (44.1％)59) (x2=20.524,P=0.000).Paroxysmal SVT had a higher termination rate on pharmacological therapy than AT (67.1％ vs.50.0％,x2=6.337,P=0.042).Patients of different age groups had significantly different response to antiarrhythmic therapy (x2=13.904,P=0.031).Children＜l year of age showed the least response to antiarrhythmic drug therapy with complete termination in 51 (55.4％)of 92.Adverse effects occurred in 9 patients (3.5％):Four patients had severe hypotensive shock using propafenone (n=3) and adenosine (n=1),and 3 patients had sinus arrest using adenosine.Conclusion Most (57.6％) children with SVT have their first clinical episode within 1 year of age,and AVRT is the most common type.TIC occurs in 13.3％ of children with SVT.Intravenous antiarrhythmic drug therapy has a 63.8％ complete termination rate for children with SVT and incidence of adverse effects is 3.5％.Propafenone and amiodarone are more effective for SVT termination in children than adenosine.Serious adverse effects may occur when using propafenone.

Patient Characteristics Associated with Hospital Admission or Antiarrhythmic Medication Changes After Emergency Department Evaluation of Supraventricular Tachycardia

Safety of adenosine for pediatric tachyarrhythmia treatment in the emergency department: a multi-hospital 10-year cross-sectional study

An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study

The Role of Troponin testing in patients with Supraventricular Tachycardia, Systematic Review and Meta-Analysis

Pediatric Emergency Department Study of Cardiac Risk in the Novel Patient (PED SCReeN)

Associated Factors and Mortality of Arrhythmia in Emergency Department: A Narrative Review

Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia

Rates and predictors of hospital and emergency department care after catheter ablation of atrial fibrillation

Five Criteria Predict Induction and Ablation of Supraventricular Tachycardia

Supraventricular Tachycardia in Infants With Congenital Diaphragmatic Hernia: Prevalence, Associations, and Outcomes

Keeping It "Current": A Review of Treatment Options for the Management of Supraventricular Tachycardia

Changes in Clinical Management Following 14-Day Ambulatory ECG Monitoring Following Emergency Department Evaluation for Unexplained Syncope

Clinical and socioeconomic predictors of shunt malfunction in the pediatric emergency department

Interhospital variability in hospital admissions for patients with low-risk syncope presenting to the emergency department

Psychotropic Medication Administration in Pediatric Emergency Departments

Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children

Can I discharge this adult patient with abnormal vital signs from the emergency department?

Emergency Department Sepsis Triage Scoring Tool Elements Associated With Hypotension Within 24 Hours in Children With Fever and Tachycardia

Complications after Electrical Cardioversion for Unstable Supraventricular Tachycardia in the Emergency Department

18-Month-Old with Lethargy and Accelerated Idioventricular Rhythm in Prehospital Setting: A Case Report

A Change of Pace: Modifying Pacemaker Settings in the Emergency Department as Emergency Medicine Physicians, A Case Report